Impact of 23‐valent pneumococcal polysaccharide vaccination on the frequency of pneumonia‐related hospitalization and survival in elderly patients with prostate cancer: A seven‐year nationwide matched cohort study

MLA

Shih-Kai Hung, et al. “Impact of 23‐valent Pneumococcal Polysaccharide Vaccination on the Frequency of Pneumonia‐related Hospitalization and Survival in Elderly Patients with Prostate Cancer: A Seven‐year Nationwide Matched Cohort Study.” Cancer, vol. 127, Sept. 2020, pp. 124–36. EBSCOhost, https://doi.org/10.1002/cncr.33203.

APA

Shih-Kai Hung, Ben Hui Yu, Chung Yi Li, Wen-Yen Chiou, Feng Chun Hsu, Chun-Liang Lai, Moon Sing Lee, Liang Cheng Chen, Li-Wen Huang, & Hon Yi Lin. (2020). Impact of 23‐valent pneumococcal polysaccharide vaccination on the frequency of pneumonia‐related hospitalization and survival in elderly patients with prostate cancer: A seven‐year nationwide matched cohort study. Cancer, 127, 124–136. https://doi.org/10.1002/cncr.33203

Chicago

Shih-Kai Hung, Ben Hui Yu, Chung Yi Li, Wen-Yen Chiou, Feng Chun Hsu, Chun-Liang Lai, Moon Sing Lee, Liang Cheng Chen, Li-Wen Huang, and Hon Yi Lin. 2020. “Impact of 23‐valent Pneumococcal Polysaccharide Vaccination on the Frequency of Pneumonia‐related Hospitalization and Survival in Elderly Patients with Prostate Cancer: A Seven‐year Nationwide Matched Cohort Study.” Cancer 127 (September): 124–36. doi:10.1002/cncr.33203.